With the start of the second Trump administration, Lawrence Tabak was anticipated to take the lead at NIH. However, an unexpected reshuffle placed Matthew Memoli at the helm, creating confusion and concern among the NIH staff. Memoli, not part of NIH's senior leadership, was largely unknown to his colleagues. This sudden change led to significant upheaval at the agency, which plays a crucial role in biomedical research funding. Long-standing bipartisan support for NIH came into question as staff feared their scientific mission and communication would be compromised under the new leadership.
All of us were on our computers trying to figure out who on Earth he was,
Collection
[
|
...
]